Published on November 11, 2016
In the past, most of the clinical trials for patients with non-Hodgkin lymphoma included different combinations of chemotherapy. Current trials focus on drugs involving molecular targets. These can be drugs affecting specific machinery within the cell or drugs that harness the power of the patient immune system. Watch now to learn from non-Hodgkin lymphoma expert Dr. Nathan Fowler.